Search results
Bristol Myers' injectable form of Opdivo meets main goal in kidney cancer trial
Reuters via AOL· 7 months agoThe new formulation of the drug that was tested in the trial used Halozyme Therapeutics' proprietary...
Bristol Myers' (BMY) Opdivo With Chemo Gets EC Nod for NSCLC
Zacks via Yahoo Finance· 10 months agoBristol Myers' (BMY) Opdivo, in combination with chemotherapy, gains European Commission approval...
Bristol Myers gets positive data in subcutaneous Opdivo trial
BioPharma Dive via Yahoo Finance· 3 months agoAn under-the-skin Opdivo shot produced similar results to an intravenous formulation in kidney...
Exeliom to focus on gastric cancer landscape with immune modulating drug
Clinical Trials Arena via Yahoo Finance· 2 weeks agoParis-based Exeliom Biosciences will focus Phase III efforts of its immune modulating drug EXL01 in...
Bristol Myers drug combo fails to meet main goal in kidney cancer trial
Reuters via Yahoo News· 2 years agoYervoy and top selling cancer drug Opdivo - is already approved in the United States as a first line...
Bristol Myers' Opdivo-Yervoy combo meets main goal in liver cancer trial
Reuters via Yahoo News· 2 months agoThe treatment, tested in patients with advanced hepatocellular carcinoma (HCC), met the main goal of...
Advanced Esophageal Cancer and Immunotherapy
Verywell Health via Yahoo News· 8 months agoA Newer Treatment OptionMedically reviewed by Gagandeep Brar, MD Immunotherapy for esophageal cancer is a newer treatment approach shown to improve the...
NHS to roll out new life-extending treatment for rare oesophagus cancer
The Independent via Yahoo News· 1 year agoThe NHS is to roll out a life-extending drug to patients with a rare form of throat and stomach...
Bristol Myers' (BMY) Opdivo Gets EC Nod for Label Expansion
Zacks via Yahoo Finance· 8 months agoBristol Myers (BMY) obtains approval in the EU for Opdivo for the adjuvant treatment of adults and...
US FDA approves Bristol-Myers' lung cancer drug
Reuters via AOL· 6 months agoThe drug, to be sold under the brand name Augtyro, is set to compete in a crowded market for lung cancer treatments that includes Bristol Myers' other...